Skip to main content

Sarai Garriga Edo

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Sarai Garriga Edo

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Mª Ángeles Carmona Ramírez

Mª Ángeles Carmona Ramírez

Research technician
Cardiovascular Diseases
Read more
Olalla Pancorbo Rosal

Olalla Pancorbo Rosal

Research technician
Stroke research
Read more
Javier Limeres Freire

Javier Limeres Freire

Predoctoral researcher
Cardiovascular Diseases
Read more
Ferran Casals Riera

Ferran Casals Riera

Research technician
Ophtalmology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.